Quality-of-care indicator | % of patients* | ||||
---|---|---|---|---|---|
United States | England† n = NA | ||||
Total n = 622 260 | Coded diagnosis only n = 56 492 | Medication use only n = 228 926 | Coded diagnosis and medication use n = 336 842 | ||
Record of BMI | 57.3 | 54.2 | 49.2 | 63.4 | 94.7 |
Record of HbA1c | 59.2 | 49.8 | 40.4 | 73.5 | 97.2 |
Last HbA1c ≤ 7% | 33.8 | 45.9 | 23.8 | 38.6 | 53.8 |
Last HbA1c ≤ 8% | 46.4 | 48.8 | 32.4 | 55.5 | 77.4 |
Last HbA1c ≤ 9% | 52.3 | 49.3 | 36.1 | 63.7 | 88.0 |
Record of the presence or absence of peripheral pulses | NR | NR | NR | NR | 91.1 |
Record of neuropathy testing | NR | NR | NR | NR | 90.8 |
Record of retinal screening | NR | NR | NR | NR | 90.9 |
Record of blood pressure | 88.0 | 86.7 | 81.5 | 92.7 | 98.3 |
Last blood pressure ≤ 145/85 mm Hg | 67.6 | 66.9 | 62.1 | 71.4 | 80.6 |
Record of microalbuminuria testing (among patients without proteinuria) | 33.4 | 24.5 | 21.4 | 43.0 | 88.5 |
Record of treatment with ACE inhibitor or angiotensin-receptor blocker (among patients with proteinuria‡ or microalbuminuria) | 85.7 | 57.1 | 95.0 | 85.8 | 80.0 |
Record of estimated glomerular filtration rate or serum creatinine testing | 69.3 | 70.0 | 54.1 | 79.6 | 97.0 |
Record of total cholesterol | 59.7 | 61.5 | 43.5 | 70.4 | 96.0 |
Last total cholesterol level ≤ 5 mmol/L | 44.6 | 41.6 | 33.0 | 53.0 | 83.0 |
Influenza vaccination in the preceding period Sept. 1 to Mar. 31 | NR | NR | NR | NR | 90.4 |
Note: ACE = angiotensin-converting enzyme, BMI = body mass index, HbA1c = glycated hemoglobin, NA = not available, NR = not recorded. *Between-column comparisons are all significant at p < 0.01. †All patients with diagnostic code for diabetes ‡Proteinuria defined as albumin (or protein) > 150 mg in a 24-hour collection or > 20 mg/dL protein or > 23 mg albumin in a urine sample.